Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Lipocine Announces Initiation of Outpatient Phase 3 Postpartum Depression Trial of LPCN 1154 [Yahoo! Finance]
Lipocine Announces Initiation of Outpatient Phase 3 Postpartum Depression Trial of LPCN 1154
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Lipocine Inc. (NASDAQ: LPCN) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.